21 results found.

Macular Edema Clinical Trial using VEGF Trap-Eye (BAY86-5321); Laser photocoagulation

Bayer - Recruiting 18 years or older.
- A Randomized, Double Masked, Active Controlled, Phase III Study of the Efficacy and Safety of Repeated Doses of Intravitreal VEGF Trap Eye in Subjects With Diabetic Macular Edema.
VEGF Trap-Eye (BAY86-5321); Laser photocoagulation

Diabetic Macular Edema (DME) Clinical Trial

Alimera Sciences - Recruiting 18 years or older.
- ILUMINATE: An Open-Label, Non-Interventional Study of the Safety and Effect of Iluvien® (Fluocinolone Acetonide 190 Micrograms Intravitreal Implant in Applicator) in Patients With Chronic Diabetic Macular Edema (DME) Insufficiently Responsive to Available Therapies.

Diabetic Macular Edema Clinical Trial using Ranibizumab and Bevacizumab; Bevacizumab

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Phase II Randomized Study to Compare Anti-VEGF Agents in the Treatment of Diabetic Macular Edema (CADME).
Ranibizumab and Bevacizumab; Bevacizumab

Diabetic Macular Edema Clinical Trial using Dextromethorphan

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Pilot Phase I/II Study for the Evaluation of Dextromethorphan as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema (MiDME2).
Dextromethorphan

Diabetic Macular Edema Clinical Trial using Ranibizumab 0.3mg/0.05cc

Southeast Retina Center, Georgia - Recruiting 18 years or older.
- Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab (ROTATE Trial).
Ranibizumab 0.3mg/0.05cc

Diabetic Retinopathy, or Macular Edema Clinical Trial using Tromethamine ketorolac; Nepafenac; Polietilenglicol 400, propilenglicol, HP guar

Hospital Juarez de Mexico - Recruiting 40 years to 80 years.
- Efficacy of Topic Antiinflammatory Therapy Treatment in Center Point Thickness Secondary to Selective Photocoagulation in Diabetic Macular Edema.
Tromethamine ketorolac; Nepafenac; Polietilenglicol 400, propilenglicol, HP guar

Proliferative Diabetic Retinopathy, or Macular Edema Clinical Trial using Ketorolac tromethamine; Alcohol polivinilico

Hospital Juarez de Mexico - Recruiting 40 years to 75 years.
- Efficacy and Safety of Topic Ketorolac to Treat Center Point Thickness Secondary to Panphotocoagulation in Proliferative Diabetic Retinopathy.
Ketorolac tromethamine; Alcohol polivinilico

Macular Edema, Diabetic Clinical Trial using Ranibizumab; Placebo; PF-04634817; Masked Sham Therapy

Pfizer - Recruiting 18 years or older.
- A Phase 2, Randomized, Double-Masked, Placebo-Controlled, Parallel Group, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist (PF-04634817) With That Of Ranibizumab In Adult Subjects With Diabetic Macular Edema.
Ranibizumab; Placebo; PF-04634817; Masked Sham Therapy

Retinal Vein Occlusion, or Macular Edema Clinical Trial using Anti-VEGF

Allergan - Recruiting 18 years or older.
- .
Anti-VEGF

Choroidal Neovascularization, Macular Edema, Glaucoma, Neovascula Clinical Trial using ranibizumab

Novartis - Recruiting 18 years or older.
- An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases..
ranibizumab

Diabetic Macular Edema Clinical Trial

Medical University of Vienna - Recruiting 18 years or older.
- The Influence of Retinal Oxygenation on the Clinical Outcomes in Eyes With Different Vitreoretinal Pathologies After a Successful Vitrectomy.

Ophthalmology, Macular Edema, or Macular Degeneration Clinical Trial using Ranibizumab (or other DME treatment)

Bayer - Recruiting N/A or older.
- POLARIS: A Non-interventional Study in Patients With Diabetic Macular Edema (DME) With Central Involvement to Assess the Effectiveness of Existing Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment Regimens.
Ranibizumab (or other DME treatment)

Non-Proliferative Diabetic Retinopathy, or Cataract Clinical Trial using Nepafenac Ophthalmic Suspension, 0.3%; Nepafenac Vehicle; Prednisolone acetate ophthalmic suspension

Alcon Research - Recruiting 18 years or older.
- Randomized, Double-Masked, Vehicle Controlled, Clinical Evaluation To Assess The Safety And Efficacy Of Nepafenac Ophthalmic Suspension, 0.3% For Improvement In Clinical Outcomes Among Diabetic Subjects Following Cataract Surgery.
Nepafenac Ophthalmic Suspension, 0.3%; Nepafenac Vehicle; Prednisolone acetate ophthalmic suspension

Non-Proliferative Diabetic Retinopathy, or Cataract Clinical Trial using Nepafenac Ophthalmic Suspension, 0.3%; Nepafenac vehicle; Prednisolone acetate ophthalmic suspension

Alcon Research - Recruiting 18 years or older.
- Randomized, Double-Masked, Vehicle Controlled, Clinical Evaluation To Assess The Safety And Efficacy Of Nepafenac Ophthalmic Suspension, 0.3% For Improvement In Clinical Outcomes Among Diabetic Subjects Following Cataract Surgery.
Nepafenac Ophthalmic Suspension, 0.3%; Nepafenac vehicle; Prednisolone acetate ophthalmic suspension

Proliferative Diabetic Retinopathy, or Macular Edema Clinical Trial using laser treatment with PASCALr; laser treatment with conventional laser system

Medical University of Vienna - Recruiting 18 years to 90 years.
- Morphological and Functional Retinal Changes Following Retinal Photocoagulation Using a Semiautomated Patterned Scanning Laser System in Proliferative Retinopathy or Macular Edema Secondary to Diabetes Mellitus or Retinal Vein Occlusion.
laser treatment with PASCALr; laser treatment with conventional laser system

Diabetic Macular Edema Clinical Trial using Ranibizumab; Bevacizumab

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) - Recruiting 18 years or older.
- Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (The BRDME Study).
Ranibizumab; Bevacizumab

Diabetic Macular Edema Clinical Trial using Bevacizumab intravitreal; Triamcinolone; Triamcinolone + Bevacizumab

Federal University of Sao Paulo - Recruiting 18 years or older.
- A Randomized, Parallel Group, Masked Clinical Study to Evaluate the Efficacy of Triamcinolone and Bevacizumab Through Intravitreal Injection With Individual or Simultaneous Drugs to Treatment of Diabetic Macular Edema.
Bevacizumab intravitreal; Triamcinolone; Triamcinolone + Bevacizumab

Diabetic Macular Edema, or Pars Plana Vitrectomy Clinical Trial using SAR 1118 0.1%; SAR 1118 1.0%; SAR 1118 5.0%

Johns Hopkins University - Recruiting 18 years or older.
- A Phase 1b, Randomized, Uncontrolled, Single-masked, Safety, Tolerability, and Pharmacokinetic Study of Multiple Doses of Three Different Concentrations (0.1%, 1.0%, 5.0%) of SAR 1118 Ophthalmic Solution in Human Subjects Undergoing Elective Pars Plana Vitrectomy (PPV).
SAR 1118 0.1%; SAR 1118 1.0%; SAR 1118 5.0%

Diabetic Macular Edema Clinical Trial using Infliximab (intravitreal, 2.0mg/0.05ml)

Mount Sinai School of Medicine - Recruiting 18 years or older.
- Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema.
Infliximab (intravitreal, 2.0mg/0.05ml)

Diabetic Macular Edema Clinical Trial using Laser photocoagulation

Federal University of Sao Paulo - Recruiting 18 years or older.
- Phase 2 Study of Micropulse 810nm Diode Laser Photocoagulation for Treatment of Diffuse Diabetic Macular Edema.
Laser photocoagulation